http://mil.news.sina.com.cn/p/2008-06-02/0921503543.html
美國成功測試超小型外科手術刀制導航彈
http://www.sina.com.cn 2008年06月02日 09:21 東方網
據俄羅斯《紐帶》網報導,美國洛克希德•馬丁公司日前成功完成了對“外科手術刀(Scalpel)”超小型制導航空炸彈的首次飛行測試。該公司發言人指出,這種新型武器主要用於對地面目標發動附帶性損傷較小的“外科手術式”精確打擊。
此次測試的地點位於加利福尼亞州境內的中國湖靶場。試驗過程中,美國海軍的兩架AV-8B“鷂”式攻擊機分別從不同的高度和距離上向目標投擲了數枚“外科手術刀”型制導炸彈。測試結果顯示,這種航彈的控制和制導系統具有非常高的準確性。
在下一階段的測試中,洛•馬公司和美國軍方將著重對“外科手術刀”戰鬥部的毀傷能力和附帶性損傷進行評估。
“外科手術刀”超小型制導航空炸彈是洛•馬公司以E-LGTR“增程型鐳射制導訓練彈”為基礎研製的一種新型精確打擊武器。該彈全重為45.5千克,長度187.5釐米,彈徑10釐米。借助新型的半主動鐳射制導系統,“外科手術刀”可以對固定和移動式目標實施準確打擊,其中,對後一類目標的打擊精度可達兩米。
洛•馬公司的設計人員認為,較高的打擊精度和較低的附帶性損傷使得這種新型制導航彈不但可用於城市條件下的作戰行動,也可用於對地面部隊提供近距離火力支援。
“外科手術刀”今後可能會用來裝備美海空軍的F-16、F/A-18和AV-8B戰鬥機,以及無人駕駛飛行器。(北斗)
http://www.lockheedmartin.com/news/press_releases/2008/MFC_052708_LMSuccessfulinFirstSCALPEL.html
Lockheed Martin Successful in First SCALPEL Flight Test
ARCHBALD, PA, May 27th, 2008 -- Lockheed Martin [NYSE: LMT] successfully conducted the first SCALPEL® weapon system release in a recent flight test at the Naval Air Warfare Center Weapons Division China Lake test range in California. This was the first in a series of tests as part of the U.S. Navy/Marine Corps/Lockheed Martin demonstration flight test program.
Three inert SCALPEL weapons were captive-carried and released from two AV-8B Harriers from the U.S. Navy’s Air Test & Evaluation Squadron VX-31. The weapons were released from various altitudes and distances from their targets, demonstrating the range and accuracy of the system. The enhanced seeker accurately guided each SCALPEL to its target, and the advanced guidance and control system consistently demonstrated its precision.
SCALPEL is a small weapon system that offers precision engagement while minimizing the potential for collateral damage in close air support and urban environments. It is a spiral development program incorporating the existing Enhanced Laser Guided Training Round airframe, minimal aircraft integration costs and development efforts, low technical and schedule risks, and affordable unit cost. SCALPEL can be employed on F-16, F/A-18, AV-8B, medium and large UAV aircraft, and other domestic and international aircraft platforms.
“We successfully demonstrated the capability of our next-generation seeker with a number of first-time events in this mission and are very pleased with its demonstrated performance,” said Joe Serra, Precision Guided Systems senior program manager at Lockheed Martin Missiles and Fire Control. “Our team is now focusing on the next development phases including warhead effectiveness demonstrations, in order to provide this critical precision-strike capability to our Warfighters.”
The team is reviewing weapon system parameters collected during the flight test to assess maximum system performance. The next phase of the flight test program will demonstrate the warhead lethality and limited collateral damage.
In addition to the SCALPEL weapon system, Lockheed Martin’s Northeastern Pennsylvania facility designs and manufactures paveway II Laser Guided Training Rounds, paveway II Laser Guided Bomb kits, paveway II Dual Mode Laser Guided Bomb kits, specialized instrumentation and control systems, and provides manufacturing services such as state-of-the-art metal crafting and electro-mechanical assemblies.
Paveway is a generic term, developed by the U.S. Air Force, for laser guided weapon systems. Lockheed Martin is a fully-qualified provider of paveway II Laser Guided Bomb kits and provides these systems to the U.S. Air Force, U.S. Navy and international customers. Lockheed Martin also supports paveway weapon systems by being the sole-source provider of the paveway II Enhanced Laser Guided Training Round.